The problem of implant-associated infection has been an increasing con
cern since foreign materials were used in surgery. Several animal mode
ls have been developed to study different aspects of such infections.
The tissue-cage model is especially suitable to analyse the role of an
timicrobial agents in device-related infections. This model perfectly
simulates the human situation in the sense that no spontaneous healing
occurs, and short-term therapy with most antibiotics does not result
in the complete elimination of the implant-associated bacteria. Quinol
ones have been increasingly used in the treatment of device-related bo
ne and joint infections. We therefore studied the role of quinolones a
gainst Staphylococcus aureus infection in the foreign-body model. In a
dditions, we analysed the effect of rifampin-quinolone combinations. C
iprofloxacin and fleroxacin completely failed to eradicate infections
with six clinical isolates of S. aureus. In contrast, rifampin alone o
r in combination was highly efficacious in eliminating tissue-cage ass
ociated S. aureus infections. The most important difference between th
ese two types of antibiotics was the complete inability of quinolones
to kill stationary-phase staphylococci, whereas rifampin had a good ba
ctericidal activity not only against growing, but also against station
ary-phase S, aureus. In conclusion, the experimental data favour the u
se of rifampin-quinolone combinations in the treatment of implant-asso
ciated infections due to S. aureus.